Back
Alnylam Pharmaceuticals Stock Predictions
Sponsored
ALNY
Sponsored
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
27
ALNY
Alnylam Pharmaceuticals
Last Price:
276.54
Seasonality Move:
5.61%
7 Day Trial
ALL ACCESS PASS
$
7
Hint at where the next big move in the market will be this month
Spot the next big move with this free book from a hedge fund managerAlnylam Pharmaceuticals Stock Forecast
- Over the next 52 weeks, Alnylam Pharmaceuticals has on average historically risen by 36.7% based on the past 20 years of stock performance.
- Alnylam Pharmaceuticals has risen higher in 14 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
-
Is Alnylam Pharmaceuticals Stock Undervalued?
The current Alnylam Pharmaceuticals [ALNY] share price is $273.15. The Score for ALNY is 27, which is 46% below its historic median score of 50, and infers higher risk than normal. - ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Alnylam Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, Alnylam Pharmaceuticals has on average historically risen by 36.7% based on the past 20 years of stock performance.
Alnylam Pharmaceuticals Stock Rating
Sell
27
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals overpriced?
- Alnylam Pharmaceuticals has risen higher in 14 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
Alnylam Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
alnylam.com
52-Week Data
52-Week High:
287.55
52-Week Low:
141.98
Prediction Charts
Market Cap:
35.07B
Price in USD:
273.15
Volume:
655.32K
Beta:
1.20
Technical Analysis
SMA50:
259.42
SMA100:
215.84
SMA200:
191.14
52-Wk Change:
51.94%
Stock Predictions
-
Is Alnylam Pharmaceuticals stock public?
Yes, Alnylam Pharmaceuticals is a publicly traded company. -
What is the Alnylam Pharmaceuticals stock quote today?
The Alnylam Pharmaceuticals stock price is 273.15 USD today. -
How to buy Alnylam Pharmaceuticals stock online?
You can buy Alnylam Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Aug-29 | 279.41 | 287.01 | 287.55 | 279.41 |
Aug-30 | 266.00 | 262.69 | 273.24 | 256.91 |
Sep-3 | 260.44 | 253.73 | 263.10 | 252.76 |
Sep-4 | 253.51 | 253.14 | 255.16 | 248.18 |
Sep-5 | 251.86 | 251.36 | 255.24 | 249.95 |
Sep-6 | 252.35 | 246.78 | 253.44 | 244.88 |
Sep-9 | 246.65 | 252.98 | 255.48 | 246.65 |
Sep-10 | 251.13 | 256.21 | 257.00 | 249.89 |
Sep-11 | 256.75 | 261.86 | 263.65 | 256.11 |
Sep-12 | 260.42 | 261.73 | 266.80 | 259.99 |
Sep-13 | 261.00 | 265.27 | 265.52 | 259.01 |
Sep-16 | 266.66 | 270.37 | 271.16 | 264.37 |
Sep-17 | 271.21 | 274.46 | 274.57 | 270.24 |
Sep-18 | 275.55 | 273.15 | 277.59 | 271.38 |
Alnylam Pharmaceuticals Earnings
Alnylam Pharmaceuticals Earnings Report: Per Share Alnylam Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Alnylam Pharmaceuticals Forecast Revenue Growth
Alnylam Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Alnylam Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.30 per share, and an increase next year of $0.57 per share.
* Alnylam Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.